Post by Cytiva

30–40% of colorectal cancer patients relapse, and current tests often detect it too late.​ Last year’s Cytiva EMEA Diagnostic Challenge winner, Pilar Cervelló Aran from IISPV, is developing a urine-based lateral-flow test to catch relapse earlier and more accessibly.​ Winning the challenge meant a week in Dassel, working hands-on with our diagnostics specialists including Klaus Hochtleitner to turn an early-stage idea into a real test concept, refining protocols, testing antibodies, and accelerating next steps with confidence.​ ​ ​ 🎥Hear Pilar share what the experience unlocked for her work:​ https://okt.to/UoIB8N